High Content Screening Market
This report studies the global high content screening market over the forecast period of 2013 to 2018. The global high content screening market was valued at an estimated $362.2 million in 2013 and is expected to reach $615.8 million by 2018, growing at a CAGR of 11.2% from 2013 to 2018.Enhanced accuracy of cell imaging and analysis systems helps in reducing the drug discovery time period and costs, which is a major factor driving the growth of this market. Furthermore, the increasing use of HCS in toxicity studies in the early phase of drug discovery is another factor that propels the growth of this market. Government support for the growth of innovative technologies and rising demand for outsourcing of drug discovery services, especially in the Asian region, are also major reasons for the high growth of this market. Based on HCS products, the instruments market commanded the largest share of 43% in 2013. However, the HCS software market is poised to grow at the highest CAGR from 2013 to 2018.
★
★
★
★
★
236 views • 4 slides
